Institute of Biostatistics and Mathematical Modelling, Frankfurt University Hospital, Goethe-University Frankfurt/Main, Frankfurt/Main, Germany.
Department of Medicine I, Frankfurt University Hospital, Goethe-University Frankfurt/Main, Frankfurt/Main, Germany.
Br J Surg. 2019 Oct;106(11):1523-1529. doi: 10.1002/bjs.11236. Epub 2019 Jul 24.
Mortality rates after liver surgery are not well documented in Germany. More than 1000 hospitals offer liver resection, but there is no central regulation of infrastructure requirements or outcome quality.
Hospital mortality rates after liver resection were analysed using the standardized hospital discharge data (Diagnosis-Related Groups, ICD-10 and German operations and procedure key codes) provided by the Research Data Centre of the Federal Statistical Office and Statistical Offices of the Länder in Wiesbaden, Germany.
A total of 110 332 liver procedures carried out between 2010 and 2015 were identified. The overall hospital mortality rate for all resections was 5·8 per cent. The mortality rate among 17 574 major hepatic procedures was 10·4 per cent. Patients who had surgery for colorectal liver metastases (CRLMs) had the lowest mortality rate among those with malignancy (5·5 per cent), followed by patients with gallbladder cancer (7·1 per cent), hepatocellular carcinoma (9·3 per cent) and intrahepatic cholangiocarcinoma (11·0 per cent). Patients with extrahepatic cholangiocarcinoma had the highest mortality rate (14·6 per cent). The mortality rate for extended hepatectomy was 16·2 per cent and the need for a biliodigestive anastomosis increased this to 25·5 per cent. Failure to rescue after complications led to mortality rates of more than 30 per cent in some subgroups. There was a significant volume-outcome relationship for CRLM surgery in very high-volume centres (mean 26-60 major resections for CRLMs per year). The mortality rate was 4·6 per cent in very high-volume centres compared with 7·5 per cent in very low-volume hospitals (odds ratio 0·60, 95 per cent c.i. 0·42 to 0·77; P < 0·001).
This analysis of outcome data after liver resection in Germany suggests that hospital mortality remains high. There should be more focused research to understand, improve or justify factors leading to this result, and consideration of centralization of liver surgery.
德国的肝外科死亡率数据记录并不完善。超过 1000 家医院提供肝切除术,但基础设施要求和手术质量的结果并无中央监管。
本研究使用德国威斯巴登联邦统计局和州统计办公室提供的标准化医院出院数据(诊断相关组、国际疾病分类第 10 版和德国手术操作关键代码)分析了肝切除术后的医院死亡率。
共确定了 2010 年至 2015 年间进行的 110332 例肝手术。所有切除术的总体医院死亡率为 5.8%。17574 例大型肝切除术的死亡率为 10.4%。结直肠癌肝转移(CRLM)患者的死亡率最低(5.5%),其次是胆囊癌(7.1%)、肝细胞癌(9.3%)和肝内胆管癌(11.0%)。肝外胆管癌患者的死亡率最高(14.6%)。扩大肝切除术的死亡率为 16.2%,需要胆肠吻合术的患者死亡率增加至 25.5%。某些亚组中并发症后的抢救失败导致死亡率超过 30%。在高容量中心(每年 CRLM 手术的平均 26-60 例),CRLM 手术存在显著的量效关系。高容量中心的死亡率为 4.6%,低容量医院为 7.5%(比值比 0.60,95%置信区间 0.42 至 0.77;P<0.001)。
本研究对德国肝切除术后的结果数据进行了分析,结果表明医院死亡率仍然较高。应该有更多的针对性研究来理解、改善或证明导致这一结果的因素,并考虑肝外科的集中化。